NPCE
Price:
$7.2
Market Cap:
$210.22M
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.[Read more]
Industry
Medical - Devices
IPO Date
2021-04-22
Stock Exchange
NASDAQ
Ticker
NPCE
According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.37. This represents a change of 1.72% compared to the average of 6.27 of the last 4 quarters.
The mean historical Current Ratio of NeuroPace, Inc. over the last ten years is 6.97. The current 6.37 Current Ratio has changed 9.05% with respect to the historical average. Over the past ten years (40 quarters), NPCE's Current Ratio was at its highest in in the June 2021 quarter at 19.24. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
6.97
Median
5.71
Minimum
0.27
Maximum
14.28
Discovering the peaks and valleys of NeuroPace, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.01%
Maximum Annual Current Ratio = 14.28
Minimum Annual Increase = -37.66%
Minimum Annual Current Ratio = 0.27
Year | Current Ratio | Change |
---|---|---|
2023 | 5.71 | -35.83% |
2022 | 8.90 | -37.66% |
2021 | 14.28 | 151.12% |
2020 | 5.69 | 2.01% |
The current Current Ratio of NeuroPace, Inc. (NPCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.63
5-year avg
6.97
10-year avg
6.97
NeuroPace, Inc.’s Current Ratio is greater than Electromed, Inc. (5.75), greater than OrthoPediatrics Corp. (4.90), greater than Surmodics, Inc. (3.98), greater than Paragon 28, Inc. (3.57), greater than Nevro Corp. (4.77), greater than NuVasive, Inc. (1.25), greater than Integer Holdings Corporation (3.29), greater than Glaukos Corporation (5.48), greater than CONMED Corporation (2.34), greater than ProSomnus, Inc. Common Stock (0.30), greater than Anika Therapeutics, Inc. (5.93), greater than Heska Corporation (5.64), less than Pulmonx Corporation (8.96), less than IRadimed Corporation (9.87), greater than Orthofix Medical Inc. (2.48), less than CVRx, Inc. (10.08), greater than Artivion, Inc. (4.63),
Company | Current Ratio | Market cap |
---|---|---|
5.75 | $149.02M | |
4.90 | $742.41M | |
3.98 | $553.99M | |
3.57 | $609.86M | |
4.77 | $193.13M | |
1.25 | $2.08B | |
3.29 | $4.33B | |
5.48 | $7.10B | |
2.34 | $2.29B | |
0.30 | $8.18M | |
5.93 | $363.41M | |
5.64 | $1.31B | |
8.96 | $286.21M | |
9.87 | $568.75M | |
2.48 | $619.96M | |
10.08 | $183.44M | |
4.63 | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NeuroPace, Inc.'s Current Ratio?
How is the Current Ratio calculated for NeuroPace, Inc. (NPCE)?
What is the highest Current Ratio for NeuroPace, Inc. (NPCE)?
What is the 3-year average Current Ratio for NeuroPace, Inc. (NPCE)?
What is the 5-year average Current Ratio for NeuroPace, Inc. (NPCE)?
How does the current Current Ratio for NeuroPace, Inc. (NPCE) compare to its historical average?